يعرض 121 - 140 نتائج من 19,167 نتيجة بحث عن '(((( c largest decrease ) OR ( ((b large) OR (i large)) decrease ))) OR ( 13 cases increased ))*', وقت الاستعلام: 2.65s تنقيح النتائج
  1. 121

    Increased and decreased proteins. حسب Diego Iacono (10785756)

    منشور في 2024
    الموضوعات:
  2. 122
  3. 123
  4. 124
  5. 125

    DataSheet_1_A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.docx حسب Jeong-Yeon Cho (11787386)

    منشور في 2024
    "…Background<p>Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) are refractory to treatment or experience relapse after initial therapy. …"
  6. 126

    Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG حسب Chaofeng Zhang (845343)

    منشور في 2024
    "…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…"
  7. 127

    Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  8. 128

    Image_4_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  9. 129

    Image_3_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  10. 130

    Supplementary Material for: STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma حسب Xiao S. (11834801)

    منشور في 2021
    "…However, the underlying mechanism of STAT3 in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has yet to be established. …"
  11. 131
  12. 132
  13. 133
  14. 134

    Supplementary Material for: High-sensitivity Troponin I Measurement in a Large Contemporary Cohort: Implications for Clinical Care حسب Esau D. (20563829)

    منشور في 2025
    "…Male sex, higher HDL-C, higher Hgb A1c, decreasing eGFR, and increasing systolic blood pressure were significant predictors of increased hsTnI. …"
  15. 135

    Predicting Electrophoretic Mobility of Proteoforms for Large-Scale Top-Down Proteomics حسب Daoyang Chen (4732431)

    منشور في 2020
    "…Our results also indicate that N-terminal acetylation and phosphorylation both decrease the proteoforms’ charge by roughly one charge unit.…"
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140